[HTML][HTML] ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours …

N Colombo, C Sessa, A du Bois, J Ledermann… - Annals of oncology, 2019 - Elsevier
The development of guidelines recommendations is one of the core activities of the
European Society for Medical Oncology (ESMO) and European Society of Gynaecologial …

Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances

L Casey, N Singh - Histopathology, 2020 - Wiley Online Library
The introduction of genomic studies has enabled assessment of the clonality of synchronous
tumours involving the ovary and other sites in the female genital tract in a definitive way. This …

Progress in the pathological arena of gynecological cancers

WG McCluggage - International Journal of Gynecology & …, 2021 - Wiley Online Library
This review covers the significant new developments in the pathological classification of
gynecological tumors. Many of these were included in the updated World Health …

The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER …

N Pavlidis, E Rassy, JB Vermorken, T Assi, J Kattan… - Cancer …, 2021 - Elsevier
Aim To determine the differential effect of the treatment periods on the survival of patients
with stage IV serous papillary peritoneal carcinoma (SPPC), fallopian tube cancers, and …

Endometrial cancer molecular risk stratification is equally prognostic for endometrioid ovarian carcinoma

P Krämer, A Talhouk, MA Brett, DS Chiu, ES Cairns… - Clinical Cancer …, 2020 - AACR
Purpose: Endometrioid ovarian carcinoma (ENOC) is generally associated with a more
favorable prognosis compared with other ovarian carcinomas. Nonetheless, current patient …

Synchronous tumours of the female reproductive tract

CB Gilks, F Kommoss - Pathology, 2018 - Elsevier
Many ovarian endometrioid carcinomas present with concurrent endometrial carcinoma, and
these organ-confined, low-grade synchronous endometrial and ovarian tumours consistently …

Somatic tumour testing establishes that bilateral DICER1‐associated ovarian Sertoli–Leydig cell tumours represent independent primary neoplasms

WG McCluggage, AL Chong, L de Kock… - …, 2020 - Wiley Online Library
Abstract Aims Sertoli–Leydig cell tumours (SLCTs) are rare ovarian neoplasms that are
commonly associated with somatic or germline DICER1 mutations, especially when of the …

Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model

J Ai, LE Pascal, KJ O'malley, JA Dar, S Isharwal, Z Qiao… - Oncogene, 2014 - nature.com
Multiple genetic alterations are associated with prostate carcinogenesis. Tumor-suppressor
genes phosphatase and tensin homolog deleted on chromosome 10 (Pten) and androgen …

Evidence of a monoclonal origin for bilateral serous tubal intraepithelial neoplasia

EE Meserve, KC Strickland, A Miron… - International Journal …, 2019 - journals.lww.com
Serous tubal intraepithelial carcinoma (STIC) is found in 10% to 60% of cases of
tuboovarian high-grade serous carcinoma (HGSC) and is presumed to be the site of origin …

Ovarian high-grade serous carcinoma: assessing pathology for site of origin, staging and post-neoadjuvant chemotherapy changes

L Casey, N Singh - Surgical Pathology Clinics, 2019 - surgpath.theclinics.com
High-grade serous (HGSC) stands apart from the other ovarian cancer histotypes in being
the most frequent, in occurring as part of a genetic predisposition in a significant proportion …